Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001140361-23-046997
Filing Date
2023-10-04
Accepted
2023-10-04 17:29:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A ef20011984_sc14d9a.htm SC 14D9/A 33459
2 EXHIBIT 99 (A)(5)(N) ef20011984_ex99-a5n.htm EX-99.(A)(5)(N) 28301
3 image00001.jpg GRAPHIC 6576
4 image00002.jpg GRAPHIC 6952
  Complete submission text file 0001140361-23-046997.txt   82452
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filed by) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Subject) CIK: 0001621443 (see all company filings)

EIN.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-88971 | Film No.: 231309005
SIC: 2834 Pharmaceutical Preparations